loadpatents
name:-0.030003070831299
name:-0.029197931289673
name:-0.018237829208374
Aagaard; Claus Patent Filings

Aagaard; Claus

Patent Applications and Registrations

Patent applications and USPTO patent grants for Aagaard; Claus.The latest application filed is for "new m.tuberculosis vaccines".

Company Profile
1.11.10
  • Aagaard; Claus - Copenhagen S DK
  • Aagaard; Claus - Cophenhagen S DK
  • Aagaard; Claus - Copenhagen DK
  • AAGAARD; CLAUS - Kobenhavn S DK
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Diagnostic reagents for improved in vivo or in vitro cell-mediated immunological diagnosis of tuberculosis
Grant 10,641,770 - Aagaard , et al.
2020-05-05
M.tuberculosis vaccines
Grant 10,004,793 - Aagaard , et al. June 26, 2
2018-06-26
Vaccines comprising TB10.4
Grant RE46,583 - Dietrich , et al. October 24, 2
2017-10-24
New M.tuberculosis Vaccines
App 20170043003 - Aagaard; Claus ;   et al.
2017-02-16
Diagnostic Reagents For Improved In Vivo Or In Vitro Cell-mediated Immunological Diagnosis Of Tuberculosis
App 20170016897 - Aagaard; Claus ;   et al.
2017-01-19
M. tuberculosis vaccines
Grant 9,526,773 - Aagaard , et al. December 27, 2
2016-12-27
A Single Or Multistage Mycobacterium Avium Subsp. Paratuberculosis Subunit Vaccine
App 20160228528 - JUNGERSEN; Gregers ;   et al.
2016-08-11
M. Tuberculosis Vaccines
App 20150290311 - Aagaard; Claus ;   et al.
2015-10-15
Tuberculosis vaccines comprising antigens expressed during the latent infection phase
Grant 8,703,151 - Aagaard , et al. April 22, 2
2014-04-22
Vaccines comprising TB10.4
Grant 8,557,258 - Dietrich , et al. October 15, 2
2013-10-15
Tuberculosis Vaccines Comprising Antigens Expressed During The Latent Infection Phase
App 20130095132 - Aagaard; Claus ;   et al.
2013-04-18
Tuberculosis vaccines comprising antigens expressed during the latent infection phase
Grant 8,293,250 - Aagaard , et al. October 23, 2
2012-10-23
Expanding The T Cell Repertoire To Include Subdominant Epitopes By Vaccination With Antigens Delivered As Protein Fragments Or Peptide Cocktails
App 20120156282 - AAGAARD; CLAUS ;   et al.
2012-06-21
Expanding the T cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails
Grant 8,105,614 - Aagaard , et al. January 31, 2
2012-01-31
Tuberculosis vaccines comprising antigens expressed during the latent infection phase
Grant 8,101,193 - Aagaard , et al. January 24, 2
2012-01-24
Tuberculosis vaccines comprising antigens expressed during the latent infection phase
Grant 7,968,105 - Aagaard , et al. June 28, 2
2011-06-28
Vaccines Comprising Tb 10.4
App 20100015171 - Dietrich; Jes ;   et al.
2010-01-21
Tuberculosis Vaccines Comprising Antigens Expressed During The Latent Infection Phase
App 20090186048 - Aagaard; Claus ;   et al.
2009-07-23
Expanding the T cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails
App 20080008724 - Aagaard; Claus ;   et al.
2008-01-10
Molecular differences between species of the M. tuberculosis complex
App 20040018574 - Behr, Marcel ;   et al.
2004-01-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed